Literature DB >> 23932356

Hematogones: an overview.

S P Chantepie1, E Cornet, V Salaün, O Reman.   

Abstract

Hematogones were initially described as mysterious cells in bone marrow smears more than 70 years ago. These cells are normal bone marrow B-lymphocyte precursors with properties that overlap those of lymphoblasts. Their morphological and immunological features are described here with an update on the knowledge of hematogones in hematological and non-hematological disorders.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  B-cell precursors; Bone marrow transplantation; Hematogones; Hematological recovery

Mesh：

Year:  2013        PMID： 23932356     DOI： 10.1016/j.leukres.2013.07.024

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  9 in total

Review 1.  Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.

Authors:  Christopher Wenzinger; Eli Williams; Alejandro A Gru
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

Review 2.  Monitoring minimal/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy.

Authors:  Zhiyu Liu; Yang Li; Ce Shi
Journal:  Int J Hematol       Date:  2021-01-27       Impact factor: 2.490

3.  Bone marrow infiltration of CD20-negative follicular lymphoma after rituximab therapy: a histological mimicker of hematogones and B-cell acute lymphoblastic leukemia/lymphoma.

Authors:  Ikuo Matsuda; Seiichi Hirota
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study.

Authors:  Giovanni Carulli; Virginia Ottaviano; Paola Sammuri; Cristiana Domenichini; Valentina Guerri; Martina Rousseau; Eugenio M Ciancia; Elena Ciabatti; Mario Petrini
Journal:  Int J Hematol       Date:  2015-05-08       Impact factor: 2.490

5.  Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors.

Authors:  Suiellen C Reis-Alves; Fabiola Traina; Konradin Metze; Irene Lorand-Metze
Journal:  Diagn Pathol       Date:  2015-04-29       Impact factor: 2.644

6.  The prognostic significance of hematogones and CD34+ myeloblasts in bone marrow for adult B-cell lymphoblastic leukemia without minimal residual disease.

Authors:  Hongyan Liao; Qin Zheng; Yongmei Jin; Tashi Chozom; Ying Zhu; Li Liu; Nenggang Jiang
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

7.  Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease.

Authors:  Rita Tavarozzi; Enrica Manzato; Riccardo Morganti; Paola Sammuri; Giulia Tarrini; Federica Ricci; Giordana Mattana; Sara Galimberti; Mario Petrini; Giovanni Carulli
Journal:  Leuk Res Rep       Date:  2021-01-08

8.  Pseudo-Kappa Light Chain Restricted Hematogones in Patients Receiving Daratumumab

Authors:  Hamza Tariq; Urooj Zahra
Journal:  Turk J Haematol       Date:  2021-11-18       Impact factor: 1.831

9.  Multiparameter Flow Cytometry to Detect Hematogones and to Assess B-lymphocyte clonality in Bone Marrow Samples from Patients with Non-Hodgkin Lymphomas.

Authors:  Giovanni Carulli; Virginia Ottaviano; Valentina Guerri; Stefano Giuntini; Paola Sammuri; Eugenio M Ciancia; Antonio Azzarà
Journal:  Hematol Rep       Date:  2014-06-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.